Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,586 | -19,985 | -20,840 | -54,225 | -27,466 |
| Depreciation Amortization | 71 | -281 | -771 | 857 | 2,569 |
| Accounts receivable | 401 | -900 | N/A | N/A | N/A |
| Other Working Capital | -1,287 | -873 | -462 | -831 | 647 |
| Other Operating Activity | 1,452 | 2,683 | 2,041 | 33,029 | 2,005 |
| Operating Cash Flow | $-15,949 | $-19,356 | $-20,032 | $-21,170 | $-22,245 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,114 | 13,363 | 10,102 | 32,516 | -54,836 |
| PPE Investments | -28 | N/A | N/A | -285 | -60 |
| Net Acquisitions | N/A | N/A | N/A | -3,320 | N/A |
| Other Investing Activity | 0 | -130 | 0 | 0 | 0 |
| Investing Cash Flow | $15,086 | $13,233 | $10,102 | $28,911 | $-54,896 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 852 | 68 | 476 | 43 | 85,524 |
| Other Financing Activity | -253 | -274 | -91 | -267 | -248 |
| Financing Cash Flow | $599 | $-206 | $385 | $-224 | $85,276 |
| Exchange Rate Effect | 11 | -55 | -16 | -10 | N/A |
| Beginning Cash Position | 16,209 | 22,593 | 32,154 | 24,647 | 16,512 |
| End Cash Position | 15,956 | 16,209 | 22,593 | 32,154 | 24,647 |
| Net Cash Flow | $-253 | $-6,384 | $-9,561 | $7,507 | $8,135 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,949 | -19,356 | -20,032 | -21,170 | -22,245 |
| Capital Expenditure | -28 | N/A | N/A | -285 | -60 |
| Free Cash Flow | -15,977 | -19,356 | -20,032 | -21,455 | -22,305 |